Intelligence Profile
Clinical Applications
Dendritic Cell (DC) vaccination is an emerging therapeutic approach primarily explored in oncology, aiming to enhance the body's immune response against cancer. Current clinical trials and studies indicate the potential applications of DC vaccines in several types of cancer.
Melanoma: A study in "Mathematical Biosciences" discusses the integration of DC vaccines with anti-PD-1 therapy for melanoma, highlighting their role in modulating immune interactions. Additionally, a completed Phase 1 clinical trial (NCT00515983) examined the use of DC vaccines loaded with allogeneic melanoma cells, aiming to provoke an immune response against melanoma tumors.
Glioblastoma: The Phase 2/3 clinical trial (NCT03548571) investigates DC immunotherapy targeting cancer stem cells in glioblastoma patients receiving standard treatments. This trial seeks to determine effectiveness and safety in boosting the immune system to target aggressive brain tumors.
Lung Cancer: An ongoing trial (NCT05886439) explores the combination of DC vaccines with PD-1 or PD-L1 inhibitors in lung cancer treatment. This approach leverages immune system engagement to target tumor cells more effectively.
Chronic Myeloid Leukemia (CML): Although a DC vaccination trial (NCT02543749) in CML was terminated, it reflects ongoing interests in utilizing DC vaccines for hematological malignancies.
Ovarian and Related Cancers: While a specific trial (NCT00801320) focused on tissue harvest for future trials rather than current application, it implies preparatory steps for potential DC vaccine trials in ovarian, fallopian tube, and primary peritoneal cancer.
Overall, DC vaccination is primarily being investigated for its potential to complement conventional cancer therapies by enhancing immune system recognition and destruction of cancer cells. However, further research is needed to fully understand its efficacy and safety across different cancer types.
Disclaimer: This summary provides general information based on current clinical evidence and is not a substitute for professional medical advice. Please consult healthcare professionals for personal medical guidance.